Over the last 20 years, the number of hospital emergency departments in nonrural areas in the U.S. has declined by nearly 30 percent, with for-profit ownership, location in a competitive market, low profit margin and safety-net ...
May 17, 2011
1
0
British drugmaker GlaxoSmithKline is in the market to buy assets in India at a total cost of up to $2.0 billion (1.5 billion euros), its chief executive said in an interview published on Monday.
Oct 3, 2011
0
0
Governments around the world ramped up the battle against the new coronavirus on Saturday by shutting borders and promising cash injections, as Spain emerged as a global hotspot registering more than 1,500 new infections ...
Mar 14, 2020
0
3
The remobilization of finger joints that have been damaged by illness or injury is an emerging market in the field of demand-driven patient care. The FingerKIt consortium, which brings together five Fraunhofer institutes, ...
Dec 1, 2022
0
30
Almost half of Australian adults are harmed by alcoholic products consumed by another person, a new study indicates, as researchers probe alcohol's widespread negative effects.
Apr 13, 2023
0
3
German chemical and pharmaceutical company Bayer AG said Thursday that its net profit rose 11.5 percent in the first quarter as new drugs, led by blood thinner Xarelto, boosted sales.
Apr 25, 2013
0
0
The abortion pill will become available in Japan for the first time after the health ministry approved the drug used to terminate early-stage pregnancy.
Apr 29, 2023
0
2
(AP)—Coca-Cola says it will work to make lower-calorie drinks and clear nutrition information more widely available around the world, intensifying a push against critics who say its drinks pack on the pounds.
May 8, 2013
0
0
The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world's largest drugmakers.
Apr 1, 2013
0
0
India's largest biotechnology firm, Biocon, and US pharmaceutical giant Pfizer said Tuesday they would scrap a joint plan to sell insulin products, sending Biocon's shares plunging.
Mar 13, 2012
0
0
